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Routine ophthalmoscopy and fundoscopy of 673 individuals revealed 42 whose irides 
failed to dilate to a clinically useful degree within 25 to 30 min after the administration of 
drops of 1 % mydracil. These individuals occurred with different frequency among the 
Aymara, Mestizo, and non-Aymara groups which made up the sample of examinees. The 
phenomenon was most common among the Aymara, less common among the Mestizos, 
and least common among the non-Aymara. Distribution of affected individuals within the 
three groups suggests that the trait is inherited. 
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Application of drops of a mydriatic to the 
conjunctival sacs produces dilation of the 
pupils in most human beings; the rapidity 
with which this occurs varies, however, with 
the specific drop and the person. The  failure 
to  dilate promptly is not a chance phenom- 
enon; indeed substantial experimental evi- 
dence supports the common clinical impres- 
sion that mydriasis takes place more slowly 
in individuals with dark irides (Barbee & 
Smith 1957, Obianwu & Rand 1965, Had-  
dad et al. 1970). Since the frequency of the 
latter persons clearly differs among ethnic 
groups, it is reasonable to presume that the 
proportion of individuals whose pupils d o  
not dilate under common dosage and in the 
customary time will differ among different 
ethnic and racial groups as, indeed, they d o  
(Howard & Lee 1927, Chen & Poth 1927, 
1929, Emiru 1971). It is. of course, a simple 
step from this conclusion to  the conjecture 
that this “aberrant” behavior is inherited. 
This presumption is strengthened by the 
known hyper-reactivity of individuals with 
Down syndrome t o  at  least one mydriatic, 
atropine (Harris & Goodman 1968), and 
Bertler & Smith’s (1971) evidence of the 
concordance in pupillary responses seen in 
monovular but not binovular twins. Still 
further support is t o  be found in observa- 
tions on  rabbits where the failure of the 
irides to  respond to the mydriatic, atropine, 
is hereditary and reflects the presence or ab- 
sence of the enzyme atropinesterase (Sawin 
& Glich 1943); for a recent review see Szo- 
rady (1973). 
Given these observations, it is reasonable 
to  assume that the failure of human irides 
to  dilate in a specified interval of time may 
reflect either qualitative or quantitative in- 
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herited biochemical differences. Rarely, 
however, have families been studied in their 
responses to a mydriatic or cyclopegic ad- 
ministered in a standardized manner. The 
data we report here are exceptional in two 
respects. First, in the populations involved 
high proportions of “non-dilators” are to be 
expected because of the generally dark co- 
loration of the iris. Second, these data em- 
brace village-wide observations conducted 
as a matter of routine in support of an epi- 
demiological study of the effects of the hy- 
poxia of altitude on cardiovascular disease. 
These populations were not intentionally 
selected, therefore, because of their possible 
responses to mydriatics, but rather as a con- 
sequence of their presumed adaptation to 
the hypoxia of altitude. While it is conceiv- 
able that the two responses may be inter- 
related, they do not appear so because high- 
land-adjusted families currently living in the 
lowlands of Chile have the same rate of 
“failures” to dilate as characterize their 
highland kinsmen and kinswomen. 
Materials and Methods 
In 1972, an investigation termed the “Multi- 
national Andean Genetic and Health Pro- 
gram” was initiated in the Departamento de  
Arica, the most northerly region of Chile, 
adjacent to Peru and Bolivia. While this 
program (which continues) has many objec- 
tives, that which is relevant here is the eval- 
uation of the burden of ophthalmic disease 
and disability among the indigenes, the Ay- 
mara, of the interior of Arica and their kins- 
folk of the coast. 
In 1973 and 1974, during the months of 
October and November, 2,096 individuals 
ranging in age from 15 days to 90 years 
were examined. The nature of this examina- 
tion has been described elsewhere (Schull & 
Rothhammer 1977); two separate ophthal- 
mic examinations were made - one by the 
physician who performed the general phys- 
ical examination, and the second by an 
ophthalmologist certified by the Ameri- 
can Board of Ophthalmology. The former 
examination was made in every instance 
where a physical examination took place; 
the latter appraisal, which gave rise to the 
data reported here, involved slightly more 
than a third of all persons examined. These 
individuals were all residents of three com- 
munities (Lluta, Putre, and Visviri) and 
within these communities they were not 
preferentially selected, except that no effort 
was made to examine routinely children less 
than 6 years of age, The examination en- 
tailed direct ophthalmoscopy as well as slit- 
lamp microscopy. A mydriatic (1 % mydra- 
cil; tropicamide, i. e., N-ethyl-2-phenyl-N- 
(4-pyridlmethyl)-hydracrylamide) was rou- 
tinely used, except where medically contra- 
indicated, to enhance visualization of the 
posterior chamber, fundus, and retina. Two 
drops were placed in the inferior cul-de-sac 
of each eye by a trained medical technician; 
pressure was then applied with cotton pled- 
gets over the lacrimal puncta for 10 s. In all 
cases, the drops were instilled by one of two 
technicians, both medically trained, and the 
techniques were identical in both eyes. Nan0 
et al. (1960) have shown that mydracil pro- 
duces dilation quickly, generally within 10 
to 15 min after its administration. Maximum 
pupillary diameter is achieved, on average, 
within 20 min of instillation of the drops, 
and the pupillary diameter remains un- 
changed for approximately 2 h, after which 
the pupil slowly returns to its original dia- 
meter, reaching the latter 8 or 9 h after the 
instillation. Mydracil is effective in all age 
groups (Nano et al. 1960, also see Smith 
1971). 
At the time of examination, the pupils of 
each individual into whose eyes mydriatics 
were instilled were “scored” by the ophthal- 
mologist as to whether clinically satisfactory 
dilation had or had not occurred. The as- 
sessment was based upon two factors: 
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Fig. 1. Simple pedigrees of the individuals who failed to respond to mydracil. Solid squares or circles denote 
individuals whose eyes failed to dilate in the standard time (20-25 min) upon the instillation of two drops of 
mydriatic; hatched squares (males) or circles (females) denote "normal responders"; empty squares or circles 
are untested individuals. The ages in years of the "affected" individuals are indicated. 
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Table 1 
A summary of the characteristics of the indi- 
viduals who failed to respond to mydracil 
Aymara Mestizo Non-Aymara 
Incidence 
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* Standard error of the mean 
1) whether or not the pupils constricted un- 
der the influence of the light of the biomi- 
croscope, and 2) whether the pupil was ade- 
quately dilated so that the ophthalmologist 
could examine the peripheral retinal struc- 
tures. The reason for recording the ade- 
quacy of dilation was in order to interpret 
whether an adequate fundoscopic examina- 
tion could be carried out and relied upon in 
each patient. 
The algorithm by which an individual is 
designated to be an Aymara, Mestizo or 
non-Aymara has been described in extenso 
elsewhere (Schull & Rothhammer 1977). 
Results and Discussion 
Figure 1 sets out our observations as a se- 
ries of brief pedigrees. None of the 42 in- 
dividuals indicated here as being “affected” 
gave evidence of any ocular or systemic 
disease which might account for his or her 
inability to respond to the mydriatic drug. 
Inspection of the pedigrees readily reveals 
that failure to dilate occurs as frequently 
among females as males, and therefore it is 
highly improbable, if many loci are in- 
volved, that a substantial number are as- 
sociated with the sex chromosomes. Sup- 
port for this contention follows from an ex- 
amination of Table 1 where the data are 
briefly summarized. Transmission does not 
accord with the supposition that one im- 
portant locus or a number of loci of lesser 
importance which determine this response 
are associated with the X chromosome. 
Our data are too limited to warrant an 
elaborate segregation analysis; however, 
superficially at least they are consistent with 
the hypothesis that “failure to dilate 
promptly” represents the homozygous state 
for an autosomal gene with appreciable fre- 
quency among Aymara. Generations are 
skipped, no predilection for one or the other 
sex is apparent, and the proportion of “af- 
fecteds” is at least superficially consonant 
with this thesis. No one of the “affected” 
individuals is, however, known to be the 
product of a consanguineous marriage. Fi- 
nally, segregation within families cannot 
here be viewed as a phenomenon secondary 
to the segregation of eye color, for the Ay- 
mara and Mestizos have, almost without ex- 
ception, dark brown irides. 
It is note-worthy that coca-chewing is 
widely practised by the Aymara, particu- 
larly those who reside in Bolivia and Peru. 
While the Chilean government has attempt- 
ed to discourage the practice, it is used cryp- 
tically throughout the year by some individ- 
uals and more openly by many at the time 
of traditional festivals, such as the ritual 
planting of the new potatoes. Cocaine itself 
is a mydriatic, and is known to produce un- 
equal effects on light and dark irides of 
human subjects (Chen & Poth 1927, 1929, 
Patil 1972). Whether persistent use of coca 
would ultimately impinge upon its effects as 
a mydriatic, or the effect of similarly acting 
drugs is not known. However, it seems an 
unlikely explanation for the present data 
because many of the nonresponders are 
children who are not normally coca-chewers. 
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